Baxiva AG
PrivateLast Round
Accelerator
Feb 23, 2026
Total Funding Raised
$3.19M
Company Overview
Baxiva AG operates in Healthcare & Life Sciences and is based in Schlieren. Its latest recorded funding round was an Accelerator round in February 2026.
Baxiva AG is a biotechnology company that develops next-generation glycoconjugate vaccines to prevent serious infections caused by Gram-negative bacteria.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Baxiva AG Comparables
Compare Baxiva AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Omniose | 83% | |
| Glycovax Pharma | 81% | |
| BiosYnth s.r.l. | 79% |
For institutional investors. Book with your work email.
Baxiva AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Feb 23, 2026 | ||||
| Grant | Aug 22, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Baxiva AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CARB-X | Grant |
| Venture Kick | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 3, 2026
Monthly visitors increased 69% MoM, reaching 1.4K.
- Mar 3, 2026
Monthly visitors grew 2090% MoM, from 39 to 854.
For institutional investors. Book with your work email.
Baxiva AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Baxiva AG's valuation, stock price, and market status.
Is Baxiva AG a public or private company?
Baxiva AG is a private company.
What is the current stock price of Baxiva AG?
Baxiva AG is a private company, so its shares have no public market price. Caplight tracks Baxiva AG's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Baxiva AG worth (valuation)?
Valuation information for Baxiva AG is not publicly available.
Can I buy Baxiva AG stock?
Baxiva AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Baxiva AG's last funding round?
Baxiva AG's most recent funding round was Accelerator on February 23, 2026.
Who are the main investors in Baxiva AG?
Key investors in Baxiva AG include CARB-X, Venture Kick.
Will Baxiva AG IPO soon?
No public IPO plans have been announced for Baxiva AG.
How can I track Baxiva AG secondary market activity?
Caplight tracks bids, offers, and trades in Baxiva AG's shares on secondary markets.